Volume Guarantee Ventilation in Preterm Infants With Frequent Episodes of Hypoxemia
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Preterm infants undergoing mechanical ventilation often present with respiratory instability which leads to fluctuations in ventilation and oxygenation. In conventional modes of mechanical ventilation used in these patients, the ventilator delivers breaths at a set rate and a constant peak inspiratory pressure.
We have demonstrated that spontaneous episodes of hypoxemia in mechanically ventilated preterm infants are frequently triggered by a loss in end-expiratory lung volume followed by decrease in tidal volume. This is due to a reduction in respiratory system compliance and increase in airway resistance.
Volume Guarantee ventilation is a mode of ventilation in which ventilator measures the exhaled tidal volume of each ventilator breath and automatically adjusts the peak inspiratory pressure to deliver the set tidal volume. We have previously shown that Volume Guarantee reduced the severity and duration of hypoxemia episodes during a period of 2 hours in preterm infants The study hypothesis is that Volume Guarantee ventilation will decrease the duration of episodes of hypoxemia when compared to conventional mechanical ventilation during routine clinical conditions and over longer periods of time.
The objective of the study is to evaluate the effects of Volume Guarantee on the duration, severity and frequency of episodes of hypoxemia in mechanically ventilated preterm infants who present with frequent hypoxemia episodes in comparison to conventional ventilation over two periods of 24 hours each and under routine clinical conditions.
| Condition | Intervention |
|---|---|
|
Episodes of Hypoxemia in Preterm Infants Undergoing Mechanical Ventilation. |
Device: volume guarantee ventilation |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Crossover Assignment Masking: Open Label Primary Purpose: Prevention |
| Official Title: | Volume Guarantee Ventilation in Preterm Infants With Frequent Episodes of Hypoxemia |
- Proportion of time spent with arterial oxygen saturation < 75% [ Time Frame: 24 hours ] [ Designated as safety issue: No ]Proportion of time spent with arterial oxygen saturation < 75%
- hypoxemia episodes [ Time Frame: 24 hours ] [ Designated as safety issue: No ]Number, frequency, mean duration and severity of hypoxemia episodes. Hypoxemic episodes will be defined as periods with arterial oxygen saturation SpO2) < 88% and < 75%.
- The mean and variability in FiO2 recorded data during each of the 24 hour periods. This will include Fraction of inspired oxygen [ Time Frame: 24 hours ] [ Designated as safety issue: No ]The mean and variability in in the fraction of inspired oxygen (FiO2).This will include the hourly-mean FiO2.
- Tidal volume [ Time Frame: 24 hours ] [ Designated as safety issue: No ]The mean and variability in tidal volume (VT) will be calculated. This will include the proportion of mechanical breaths with VT < 3 and < 1.5 ml/Kg.
- Minute ventilation [ Time Frame: 24 hours ] [ Designated as safety issue: No ]The mean and variability in total, mechanical and spontaneous minute ventilation will be calculated.
| Estimated Enrollment: | 30 |
| Study Start Date: | November 2012 |
| Estimated Study Completion Date: | November 2014 |
| Estimated Primary Completion Date: | November 2014 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Active Comparator: Conventional-Volume Guarantee
This study Arm will consist of a 24-hour period during which the infant receives conventional mechanical ventilation and a second 24 hour period during which the infant receives volume guarantee ventilation.
|
Device: volume guarantee ventilation
The study will consist of two arms. In one arm, a 24-hour period during which the infant receives conventional mechanical ventilation and a second 24 hour period during which the infant receives volume guarantee ventilation. In the other Arm, a 24-hour period during which the infant receives volume guarantee ventilation and a second 24 hour period during which the infant receives conventional mechanical ventilation. These two arms will be assigned at random. Both conventional and volume guarantee ventilation will be provided by the same neonatal ventilator (AVEA, CareFusion Inc, Yorba Linda, CA). During the 24 hour period of conventional ventilation, the infant will receive mechanical ventilation with the settings determined by the clinical team. During volume guarantee ventilation, the set tidal volume to be maintained by the ventilator will be the average tidal volume delivered by the ventilator prior to start of study. |
|
Active Comparator: Volume Guarantee-Conventional
This study Arm will consist of a 24-hour period during which the infant receives volume guarantee ventilation and a second 24 hour period during which the infant receives conventional mechanical ventilation.
|
Device: volume guarantee ventilation
The study will consist of two arms. In one arm, a 24-hour period during which the infant receives conventional mechanical ventilation and a second 24 hour period during which the infant receives volume guarantee ventilation. In the other Arm, a 24-hour period during which the infant receives volume guarantee ventilation and a second 24 hour period during which the infant receives conventional mechanical ventilation. These two arms will be assigned at random. Both conventional and volume guarantee ventilation will be provided by the same neonatal ventilator (AVEA, CareFusion Inc, Yorba Linda, CA). During the 24 hour period of conventional ventilation, the infant will receive mechanical ventilation with the settings determined by the clinical team. During volume guarantee ventilation, the set tidal volume to be maintained by the ventilator will be the average tidal volume delivered by the ventilator prior to start of study. |
Eligibility| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Born at less than 32 weeks of gestational age.
- Requiring mechanical ventilation on a mandatory ventilator rate greater than or equal to 20 per minute and receiving a mean tidal volume of at least 4 ml/kg.
- Presenting with 4 or more episodes of hypoxemia, defined as oxygen saturation less than 75%, in the 8 hours prior to the study.
Exclusion Criteria:
- Major congenital anomalies.
- Hemodynamic instability requiring inotropes within 72 hours prior to the study
- Culture proven sepsis within 72 hours prior to the study.
- Diagnosis of pulmonary interstitial emphysema or pneumothorax within the 72 hours prior to the study.
Contacts and Locations| Contact: Nelson Claure, M.Sc., Ph.D. | 3055856408 | nclaure@miami.edu |
| Contact: Carmen D'Ugard, M.D., R.R.T. | 3055856408 | cdugard@med.miami.edu |
| United States, Florida | |
| Newborn Intensitve Care Unit at Holtz Children's Hospital of Jackson Health System | Recruiting |
| Miami, Florida, United States, 33136 | |
| Contact: Carmen D'Ugard, M.D., R.R.T. 305-585-6408 cdugard@med.miami.edu | |
| Principal Investigator: Nelson Claure, M.Sc., Ph.D. | |
| Principal Investigator: Eduardo Bancalari, M.D. | |
| Principal Investigator: | Nelson Claure, M.Sc., Ph.D. | University of Miami |
| Principal Investigator: | Eduardo Bancalari, M.D. | University of Miami |
More Information
No publications provided
| Responsible Party: | Nelson Claure, Research Associate Professor of Pediatrics, University of Miami |
| ClinicalTrials.gov Identifier: | NCT01727505 History of Changes |
| Other Study ID Numbers: | 20120623 |
| Study First Received: | November 8, 2012 |
| Last Updated: | December 12, 2012 |
| Health Authority: | United States: Data and Safety Monitoring Board United States: Institutional Review Board |
Keywords provided by University of Miami:
|
hypoxemia desaturation mechanical ventilation preterm infants volume guarantee ventilation |
Additional relevant MeSH terms:
|
Anoxia Signs and Symptoms, Respiratory Signs and Symptoms |
ClinicalTrials.gov processed this record on May 21, 2013